KRAS and neoplasm: To explore whether the mutations of key CRC genes (ie APC, TP53 and KRAS) affect the differential enrichment of somatic mutations in different regions, we performed waterfall plots for top 30 mutated genes in CRC and found the top 10 genes were mutated in more than 10% of CRC tumours.